SCHEMBL19239494

SCHEMBL19239494

CCN1C(=O)c2ccc3c4c(Cl)cc5c6c(cc(Cl)c(c7ccc(c2c37)C1=O)c64)C(=O)N(CC)C5=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
KDM4E B2RXH2 3/20 0.60
LMNA P02545 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.50
CYP1B1 Q16678 5/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
KMT2A Q03164 1/20 0.49
ATM Q13315 1/20 0.49
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
TERT O14746 5/20 0.48
CLTC Q00610 1/20 0.42
STAT3 P40763 1/20 0.42
HIF1A Q16665 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 2/20 0.42
CASP1 P29466 1/20 0.42
MPI P34949 1/20 0.42
CACNA1B Q00975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19239493 0.95 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1
SCHEMBL12744276 0.85 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1
SCHEMBL19245389 0.85 TERT (0.44) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1
SCHEMBL24383910 0.84 TERT (0.44) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1
SCHEMBL17515114 0.84 STAT3 (0.49) ALDH1A1KDM4ELMNAL3MBTL1MEN1
SCHEMBL19239499 0.83 ALDH1A1 (0.57) ALDH1A1KDM4ELMNAL3MBTL1MEN1
SCHEMBL17514372 0.82 NPSR1 (0.54) ALDH1A1LMNACYP1B1MEN1USP2
SCHEMBL13784283 0.82 TERT (0.48) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1
SCHEMBL12744274 0.82 CYP1B1 (0.56) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1
SCHEMBL10062486 0.82 TERT (0.61) ALDH1A1KDM4ELMNAL3MBTL1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM BASF SE (DE) 2017-08-31 US disclosed
US-20170237005-A1 PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-08-17 US disclosed
US-20150307465-A1 Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use MERCK SHARP & DOHME CORP. (US) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307465-A1 Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use BACE1, BACE2, APP ALDH1A1 752/4885KDM4E 3372/4885LMNA 496/4885
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM CRY1, NEFM, OR10J3 ALDH1A1 4298/4885KDM4E 4719/4885LMNA 4146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.